• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别影响住院的新冠病毒感染患者的白细胞介素-23血清水平。

Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.

作者信息

Abbasifard Mitra, Kazemi Arababadi Mohammad, Bahrehmand Fatemeh, Bazmandegan Gholamreza, Shabani Shahrbabaki Ziba, Kamiab Zahra

机构信息

Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences Rafsanjan, Iran.

Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences Rafsanjan, Iran.

出版信息

Am J Clin Exp Immunol. 2022 Apr 15;11(2):28-33. eCollection 2022.

PMID:35601022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9123428/
Abstract

Cytokine storm is a main complication in the hospitalized patients, who are infected with the novel coronavirus (COVID-19). The pro-inflammatory cytokines are the main causes of the cytokine storm, however, the roles played by IL-17A, IL-23 and CCL3 are yet to be clarified completely. This prospective study was aimed to explore serum levels of these cytokines in the hospitalized patients infected by COVID-19. Serum levels of IL-17A, IL-23 and CCL3 were measured in 30 COVID-19 infected patients in parallel with 30 healthy controls using ELISA technique. Although serum levels of IL-17A, IL-23 and CCL3 did not alter in the patients in comparison to healthy controls, male patients had higher serum levels of IL-23 than women. Hypertension, type 2 diabetes, lung involvement and age did not affect serum levels of IL-17A, IL-23 and CCL3 in the patients. It appears that IL-17A, IL-23 and CCL3 do not participate in the pro-inflammatory responses in Iranian hospitalized COVID-19 infected patients. However, the gender can be considered as a risk factor for production of more IL-23, which needs to be explored further.

摘要

细胞因子风暴是新型冠状病毒(COVID-19)感染住院患者的主要并发症。促炎细胞因子是细胞因子风暴的主要原因,然而,白细胞介素-17A(IL-17A)、白细胞介素-23(IL-23)和趋化因子配体3(CCL3)所起的作用尚未完全阐明。这项前瞻性研究旨在探讨COVID-19感染住院患者血清中这些细胞因子的水平。采用酶联免疫吸附测定(ELISA)技术,对30例COVID-19感染患者和30例健康对照者的血清IL-17A、IL-23和CCL3水平进行了平行检测。尽管与健康对照者相比,患者血清中IL-17A、IL-23和CCL3水平没有变化,但男性患者血清IL-23水平高于女性。高血压、2型糖尿病、肺部受累情况和年龄对患者血清IL-17A、IL-23和CCL3水平没有影响。看来,IL-17A、IL-23和CCL3在伊朗COVID-19感染住院患者的促炎反应中不发挥作用。然而,性别可被视为产生更多IL-23的一个风险因素,这有待进一步研究。

相似文献

1
Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.性别影响住院的新冠病毒感染患者的白细胞介素-23血清水平。
Am J Clin Exp Immunol. 2022 Apr 15;11(2):28-33. eCollection 2022.
2
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Iranian population.伊朗人群中白细胞介素-29 和 microRNA185-5p 的系统水平与严重 COVID-19 无关。
Virol J. 2023 May 5;20(1):88. doi: 10.1186/s12985-023-02046-7.
3
Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.治疗和未经治疗的 HCV 感染患者中促炎和调节细胞因子水平的基因型相关变异。
Med Microbiol Immunol. 2018 Feb;207(1):65-74. doi: 10.1007/s00430-017-0527-9. Epub 2017 Nov 17.
4
Interleukin 17A: A Potential Target for Its Plausible Roles in the Pathogenesis of Idiopathic Epistaxis.白细胞介素17A:因其在特发性鼻出血发病机制中可能发挥的作用而成为一个潜在靶点。
Iran J Otorhinolaryngol. 2022 Jan;34(120):45-53. doi: 10.22038/IJORL.2021.51208.2731.
5
Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.炎症细胞因子:COVID-19患者的IL-17A信号通路及当前治疗策略
J Inflamm Res. 2020 Oct 6;13:673-680. doi: 10.2147/JIR.S278335. eCollection 2020.
6
Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome.白细胞介素-32和白细胞介素-17A单核苷酸多态性及血清水平与多囊卵巢综合征的关联
Iran J Allergy Asthma Immunol. 2019 Feb;18(1):91-99.
7
IL-17A )rs2275913; G197A) gene polymorphism as predictor for disease severity and its correlation with IL-17 serum levels in COVID-19 patients.白细胞介素-17A(rs2275913; G197A)基因多态性作为 COVID-19 患者疾病严重程度的预测因子及其与血清白细胞介素-17 水平的相关性。
Egypt J Immunol. 2022 Jul;29(3):90-98.
8
A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome.抗合成酶综合征患者血清白细胞介素-17A的前瞻性横断面研究。
Clin Rheumatol. 2020 Sep;39(9):2763-2771. doi: 10.1007/s10067-020-05013-7. Epub 2020 Mar 9.
9
High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis.血浆白细胞介素-17A 水平升高与朗格汉斯细胞组织细胞增生症的严重神经后遗症有关。
Cytokine. 2020 Feb;126:154877. doi: 10.1016/j.cyto.2019.154877. Epub 2019 Oct 16.
10
Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者的白细胞介素-17A、肿瘤坏死因子-α、白细胞介素-18、白细胞介素-10循环水平及认知功能
Neurol Res. 2018 Mar;40(3):153-159. doi: 10.1080/01616412.2017.1420522. Epub 2018 Jan 3.

引用本文的文献

1
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge.经受住风暴:年龄和生物制剂如何影响COVID-19细胞因子风暴
Pathogens. 2025 Apr 3;14(4):346. doi: 10.3390/pathogens14040346.
2
The presence, severity, and onset of preeclampsia is associated with maternal interleukin-23 level: A case-control study.子痫前期的存在、严重程度及发病与母体白细胞介素-23水平相关:一项病例对照研究。
Int J Reprod Biomed. 2023 May 8;21(4):295-302. doi: 10.18502/ijrm.v21i4.13269. eCollection 2023 May.

本文引用的文献

1
COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.COVID-19 与免疫调控:基础与转化医学到临床应用
J Dtsch Dermatol Ges. 2020 Aug;18(8):795-807. doi: 10.1111/ddg.14169. Epub 2020 Aug 6.
2
Potential role of IL-17 blocking agents in the treatment of severe COVID-19?IL-17阻断剂在重症新型冠状病毒肺炎治疗中的潜在作用?
Br J Clin Pharmacol. 2021 Mar;87(3):1578-1581. doi: 10.1111/bcp.14437. Epub 2020 Jul 5.
3
COVID 19: a clue from innate immunity.COVID-19:先天免疫的线索。
Immunol Res. 2020 Jun;68(3):161-168. doi: 10.1007/s12026-020-09137-5.
4
May IL-17 have a role in COVID-19 infection?白细胞介素-17在新型冠状病毒肺炎感染中起作用吗?
Med Hypotheses. 2020 Jul;140:109749. doi: 10.1016/j.mehy.2020.109749. Epub 2020 Apr 22.
5
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
6
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?我们能否使用白细胞介素 6(IL-6)阻断剂治疗 2019 冠状病毒病(COVID-19)引起的细胞因子释放综合征(CRS)?
J Autoimmun. 2020 Jul;111:102452. doi: 10.1016/j.jaut.2020.102452. Epub 2020 Apr 10.
7
Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.冠状病毒 COV-19/SARS-CoV-2 对女性的影响小于男性:病毒感染的临床反应。
J Biol Regul Homeost Agents. 2020;34(2):339-343. doi: 10.23812/Editorial-Conti-3.
8
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子(包括白细胞介素 6)在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
9
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.COVID-19 的病毒学、流行病学、发病机制和防控。
Viruses. 2020 Mar 27;12(4):372. doi: 10.3390/v12040372.
10
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.COVID-19 患者的临床特征、出院率和死亡率的荟萃分析。
J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23.